These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28450104)

  • 1. Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.
    Moroncini G; Cuccioloni M; Mozzicafreddo M; Pozniak KN; Grieco A; Paolini C; Tonnini C; Spadoni T; Svegliati S; Funaro A; Angeletti M; Gabrielli A
    Anal Biochem; 2017 Jul; 528():26-33. PubMed ID: 28450104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
    Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
    Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis.
    Classen JF; Henrohn D; Rorsman F; Lennartsson J; Lauwerys BR; Wikström G; Rorsman C; Lenglez S; Franck-Larsson K; Tomasi JP; Kämpe O; Vanthuyne M; Houssiau FA; Demoulin JB
    Arthritis Rheum; 2009 Apr; 60(4):1137-44. PubMed ID: 19333949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus.
    Kurasawa K; Arai S; Owada T; Maezawa R; Kumano K; Fukuda T
    Mod Rheumatol; 2010 Oct; 20(5):458-65. PubMed ID: 20490598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis.
    Balada E; Simeón-Aznar CP; Ordi-Ros J; Rosa-Leyva M; Selva-O'Callaghan A; Pardos-Gea J; Fonollosa-Pla V; Vilardell-Tarrés M
    Ann Rheum Dis; 2008 Jul; 67(7):1027-9. PubMed ID: 18272670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis.
    Moroncini G; Svegliati S; Grieco A; Cuccioloni M; Mozzicafreddo M; Paolini C; Agarbati S; Spadoni T; Amoresano A; Pinto G; Chen Q; Benfaremo D; Tonnini C; Senzacqua M; Alizzi S; Nieto K; Finke D; Viola N; Amico D; Galgani M; Gasparini S; Zuccatosta L; Menzo S; Müller M; Kleinschmidt J; Funaro A; Giordano A; La Cava A; Dorfmüller P; Amoroso A; Pucci P; Pezone A; Avvedimento EV; Gabrielli A
    Arthritis Rheumatol; 2024 Apr; 76(4):620-630. PubMed ID: 37975161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.
    Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G
    Front Immunol; 2018; 9():428. PubMed ID: 29623076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
    Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
    Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis.
    Odaka M; Hasegawa M; Hamaguchi Y; Ishiura N; Kumada S; Matsushita T; Komura K; Sato S; Takehara K; Fujimoto M
    Clin Exp Immunol; 2010 Feb; 159(2):176-84. PubMed ID: 19919568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
    Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
    Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
    Ogawa F; Shimizu K; Hara T; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
    Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
    Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.